NR507/ NR 507-Week 5- 8 Final Exam (Latest 2025/
2026 Update) Advanced Pathophysiology | Questions
and Verified Answers| 100% Correct |Grade A –
Chamberlain Description: NR507- Midterm Advanced
Patho- cardiac, pulmonary, hematology, renal
Impairment in Daily Life - :answers :Anxiety affects work or meeting deadlines.
Substance Abuse Exclusion - :answers :Symptoms cannot be due to drugs or
conditions.
SSRIs for Anxiety - :answers :First-line agents for various anxiety disorders.
Buspirone - :answers :Used when chronic anxiolysis is needed.
Benzodiazepines - :answers :Psychoactive drugs with relaxing effects, risk
dependence.
Performance-only SAD - :answers :Use beta-blockers or benzodiazepines before
performance.
CBT for Recurring Performances - :answers :Cognitive Behavioral Therapy
recommended for treatment.
,Short Course of BZD Therapy - :answers :Consider for anxiety exacerbations, e.g.,
alprazolam.
Venlafaxine - :answers :Start at 37.5 mg, increase to 150 mg.
Paroxetine - :answers :Target dose of 40 mg daily for anxiety.
Avoid Chronic BZD Therapy - :answers :Due to risk of dependence.
Tapering Therapy - :answers :Gradual reduction of medication dosage over weeks.
Withdrawal Symptoms - :answers :Physical or psychological effects after stopping
medication.
Buspirone - :answers :Anxiolytic medication for chronic anxiety treatment.
Anorexia Nervosa - :answers :Eating disorder with extreme weight restriction.
BMI Classification - :answers :Extreme anorexia: BMI <15; mild: BMI >17.
Cognitive Behavioral Therapy (CBT) - :answers :Psychological treatment for anorexia
and bulimia.
SCOFF Tool - :answers :Screening tool for eating disorders: Sick, Control, One, Fat,
Food.
Bulimia Nervosa - :answers :Binge eating followed by compensatory behaviors.
, Binge Eating Definition - :answers :Eating large amounts in a short time.
Compensatory Behavior - :answers :Actions to prevent weight gain post-binge.
Fluoxetine - :answers :First-line treatment for bulimia nervosa.
Electrolyte Disturbance - :answers :Imbalance of minerals affecting bodily functions.
Inpatient Care - :answers :Hospitalization for severe eating disorder cases.
Malnutrition Assessment - :answers :Evaluate nutritional status at first patient visit.
Refeeding Complications - :answers :Potential issues like edema during nutritional
recovery.
Potassium Chloride Treatment - :answers :Used for treating hypokalemia in patients.
Bone Mineral Density Monitoring - :answers :Assess bone health in anorexic patients.
Melanoma - :answers :Most serious form of skin cancer.
Risk Factors for Melanoma - :answers :Includes family history, light skin, and
irregular nevi.
Multidisciplinary Team Approach - :answers :Coordinated care involving various
healthcare professionals.
Weight Gain Recommendation - :answers :Aim for 1 to 2 lbs gain weekly.
2026 Update) Advanced Pathophysiology | Questions
and Verified Answers| 100% Correct |Grade A –
Chamberlain Description: NR507- Midterm Advanced
Patho- cardiac, pulmonary, hematology, renal
Impairment in Daily Life - :answers :Anxiety affects work or meeting deadlines.
Substance Abuse Exclusion - :answers :Symptoms cannot be due to drugs or
conditions.
SSRIs for Anxiety - :answers :First-line agents for various anxiety disorders.
Buspirone - :answers :Used when chronic anxiolysis is needed.
Benzodiazepines - :answers :Psychoactive drugs with relaxing effects, risk
dependence.
Performance-only SAD - :answers :Use beta-blockers or benzodiazepines before
performance.
CBT for Recurring Performances - :answers :Cognitive Behavioral Therapy
recommended for treatment.
,Short Course of BZD Therapy - :answers :Consider for anxiety exacerbations, e.g.,
alprazolam.
Venlafaxine - :answers :Start at 37.5 mg, increase to 150 mg.
Paroxetine - :answers :Target dose of 40 mg daily for anxiety.
Avoid Chronic BZD Therapy - :answers :Due to risk of dependence.
Tapering Therapy - :answers :Gradual reduction of medication dosage over weeks.
Withdrawal Symptoms - :answers :Physical or psychological effects after stopping
medication.
Buspirone - :answers :Anxiolytic medication for chronic anxiety treatment.
Anorexia Nervosa - :answers :Eating disorder with extreme weight restriction.
BMI Classification - :answers :Extreme anorexia: BMI <15; mild: BMI >17.
Cognitive Behavioral Therapy (CBT) - :answers :Psychological treatment for anorexia
and bulimia.
SCOFF Tool - :answers :Screening tool for eating disorders: Sick, Control, One, Fat,
Food.
Bulimia Nervosa - :answers :Binge eating followed by compensatory behaviors.
, Binge Eating Definition - :answers :Eating large amounts in a short time.
Compensatory Behavior - :answers :Actions to prevent weight gain post-binge.
Fluoxetine - :answers :First-line treatment for bulimia nervosa.
Electrolyte Disturbance - :answers :Imbalance of minerals affecting bodily functions.
Inpatient Care - :answers :Hospitalization for severe eating disorder cases.
Malnutrition Assessment - :answers :Evaluate nutritional status at first patient visit.
Refeeding Complications - :answers :Potential issues like edema during nutritional
recovery.
Potassium Chloride Treatment - :answers :Used for treating hypokalemia in patients.
Bone Mineral Density Monitoring - :answers :Assess bone health in anorexic patients.
Melanoma - :answers :Most serious form of skin cancer.
Risk Factors for Melanoma - :answers :Includes family history, light skin, and
irregular nevi.
Multidisciplinary Team Approach - :answers :Coordinated care involving various
healthcare professionals.
Weight Gain Recommendation - :answers :Aim for 1 to 2 lbs gain weekly.
